[Clinical effects of naftopidil on nocturia associated with benign prostatic hyperplasia].
[Clinical effects of naftopidil on nocturia associated with benign prostatic hyperplasia].
复制标题
萘哌地尔治疗良性前列腺增生相关夜尿症的临床效果
DOI：
--
复制
发表时间：
2003
期刊：
影响因子：
--
通讯作者：
I. Araki
中科院分区：
文献类型：
--
作者：
Y. Sugino;S. Fukuzawa;H. Takeuchi;Y. Taki;T. Hashimura;Tomoki Soeda;I. Araki
我们研究了萘哌地尔（50 mg/天）对35例（62-80岁）良性前列腺增生相关性前列腺炎的疗效。BPH > 20 ml，排尿3次以上，国际前列腺症状评分（IPSS）> 7分，生活质量评分（QOL）< 1分，最大尿流率（Qmax）< 15 ml/sec。他们接受萘哌地尔治疗超过6周。分析两组患者的IPSS、QOL、Qmax、排尿量及不良反应。萘哌地尔对与良性前列腺增生相关的前列腺炎有效，尤其是在夜间服用。
We studied the efficacy of naftopidil (50 mg/day) on nocturia associated with benign prostatic hyperplasia in 35 patients (62-80 years old). The patients had BPH > 20 ml, nocturia, more than 3 times, international prostate symptom score (IPSS) > 7, quality of life score (QOL) < 1, and maximum flow rate (Qmax) < 15 ml/sec. They received naftopidil for more than 6 weeks. IPSS, QOL, Qmax, micturition volume, and side effects were analyzed. Naftopidil was effective for nocturia associated with benign prostatic hyperplasia, especially when taken at night.